市场调查报告书
商品编码
1451223
2024-2032 年按产品类型、应用、最终用途产业和地区分類的低温冷冻机市场报告Cryogenic Freezers Market Report by Product Type, Application, End Use Industry, and Region 2024-2032 |
2023年,全球低温冷冻机市场规模达到2.075亿美元。展望未来, IMARC Group预计到2032年市场规模将达到3.306亿美元,2024-2032年复合年增长率(CAGR)为5.2%。生物银行领域对生物样本长期保存的需求不断增长,基因组研究中产品需求的增加以及超低温储存需求的迫切性是推动市场发展的一些因素。
低温冷冻机是一种专门的冷冻系统,旨在保持超低温,通常范围为 -150°C 至 -196°C(-238°F 至 -320°F)。这些冰箱主要设计用于长时间保存生物样本,例如血液、组织和细胞,同时最大限度地减少细胞变化。这些装置采用先进的隔热材料和冷却技术製成,可有效达到并维持超低温设定。儘管也可以使用机械系统,但它们通常使用液态氮或液态二氧化碳作为冷媒。这些冰柜背后的机制涉及两级冷冻过程;第一阶段通常将温度降至-40°C左右,后续阶段则达到超低温。这种双重冷却过程可确保最小的热波动,使这些冷冻机在各种研究、医疗和工业应用中发挥关键作用。
全球低温冰箱市场主要是由生物银行业对长期保存生物样本的需求不断增长所推动的。与此一致,基因组研究中不断增长的产品需求也提升了市场前景。此外,在COVID-19大流行期间,超低温储存需求的日益紧迫是推动市场成长的重要因素。除此之外,製药和医疗保健行业也越来越多地采用来维持药物功效也推动了市场扩张。此外,将先进的即时监控技术(例如物联网(IoT))整合到这些冰柜中呈现出积极的市场前景。医疗保健和食品业对高效冷链管理的严格监管要求也推动了市场的发展。除此之外,人们对医学研究中样本完整性重要性的认识不断提高,正在推动市场的采用。促进市场发展的其他一些因素包括需要可靠的超低温储存的器官移植数量的增加,以及对个人化医疗的日益依赖。
医学研究和诊断的进展
影响低温冷冻机市场的关键因素之一是医学研究和诊断的进步。随着医疗机构和研究组织深入研究分子层面的疾病,在超低温下储存生物样本的需求变得至关重要。这使得精确分析成为可能,并为发现新的治疗方法、药物和疫苗铺平了道路。随着我们看到针对癌症、阿兹海默症和各种传染病等复杂疾病的研究项目数量不断增加,对可靠、大容量低温储存解决方案的需求也在不断增长。高通量筛选和复杂测定需要大量保存的生物物质。只有透过超低温储存,这些样本才能长时间保持活力,确保多年研究和可能挽救生命的研究的完整性。
加强监管和品质标准
市场的另一个主要驱动力是全球范围内对监管监督和品质标准的加强关注。生物样本的储存不仅是为了方便,而且往往是监管要求。一些国家的许多机构都面临着关于如何储存、处理和记录生物材料的更严格的指导方针。此类法规在检查新药功效和安全性的临床试验和药物研究中尤其严格。不遵守这些规定可能会导致严重的后果,包括经济处罚和声誉损失。因此,采用符合这些高品质标准的低温冷冻机不是可选的,而是必要的。此类储存解决方案的实施可确保合规性,从而降低风险并促进更顺利的研究过程。
生技公司的全球扩张
生技公司在全球的扩张是推动低温冷冻机市场的重要力量。随着这些组织扩大业务范围,从国内市场进入国际舞台,对强大、可靠和集中式低温储存解决方案的需求变得越来越重要。这些公司经常参与跨越多个科学学科的突破性研究和产品开发活动,从基因组学到个人化医疗,甚至农业生物技术。在如此广泛的应用中使用的生物样本的价值是巨大的,无论是在经济价值还是科学实用性方面。随着公司规模的扩大,管理这些生物资产的复杂性也呈指数级增长。标准化多个地点的存储,同时确保每个地点符合各自管辖范围内必要的品质和安全法规,成为一项重大的物流挑战。
The global cryogenic freezers market size reached US$ 207.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 330.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The rising demand in bio-banking sectors for the long-term preservation of biological samples, increasing product requirements in genomic research, and rising urgency of ultra-low temperature storage needs represent some of the factors that are propelling the market.
A cryogenic freezer is a specialized refrigeration system engineered to maintain ultra-low temperatures, typically ranging from -150°C to -196°C (-238°F to -320°F). These freezers are principally designed to preserve biological samples, such as blood, tissues, and cells, for extended periods while minimizing cellular changes. Built with advanced insulation materials and cooling technologies, these units efficiently attain and sustain their ultra-low temperature settings. They often employ liquid nitrogen or liquid carbon dioxide as the refrigerant, although mechanical systems are also available. The mechanism behind these freezers involves a two-stage refrigeration process; the first stage usually brings the temperature down to around -40°C, and the subsequent stage achieves the ultra-low temperature. This double-cooling process ensures minimal thermal fluctuations, making these freezers pivotal in various research, medical, and industrial applications.
The global market for cryogenic freezers is primarily driven by the rising demand in bio-banking sectors for the long-term preservation of biological samples. In line with this, the increasing product requirements in genomic research are also elevating the market's prospects. Moreover, the rising urgency of ultra-low temperature storage needs amid the COVID-19 pandemic acts as a significant factor contributing to market growth. In addition to this, the growing adoption within the pharmaceutical and healthcare industries to preserve drug efficacy is also propelling market expansion. Furthermore, the integration of advanced, real-time monitoring technologies such as the internet of things (IoT) into these freezers presents a positive market outlook. The market is also fueled by stringent regulatory requirements for efficient cold chain management in healthcare and food industries. Alongside this, greater awareness regarding the importance of specimen integrity in medical research is driving market adoption. Some of the other factors contributing to the market include the increasing number of organ transplants that require reliable ultra-low temperature storage, and the growing reliance on personalized medicine.
Advances in Medical Research and Diagnostics
One pivotal factor influencing the market for cryogenic freezers is the advancements in medical research and diagnostics. As healthcare institutions and research organizations delve deeper into understanding diseases at a molecular level, the need for storing biological samples at ultra-low temperatures becomes paramount. This enables precise analyses and paves the way for the discovery of new treatment methods, medications, and vaccines. As we see an increase in the number of research programs focused on complex diseases such as cancer, Alzheimer's, and various infectious diseases, the demand for reliable and high-capacity cryogenic storage solutions grows. High-throughput screenings and complex assays require large volumes of preserved biological matter. Only with ultra-low temperature storage can these samples be kept viable for extended periods, ensuring the integrity of years-long studies and potentially life-saving research.
Increased regulatory oversight and quality standards
Another major driver for the market is the intensified focus on regulatory oversight and quality standards across the globe. The storage of biological samples is not just a matter of convenience but often a regulatory requirement. Numerous institutions in several countries are facing stricter guidelines about how biological materials should be stored, handled, and documented. Such regulations are particularly rigorous in clinical trials and pharmaceutical research where the efficacy and safety of new drugs are examined. Non-compliance with these regulations can lead to severe repercussions, including financial penalties and loss of reputation. Therefore, the adoption of cryogenic freezers that meet these high-quality standards is not optional but essential. The implementation of such storage solutions assures compliance, thereby mitigating risks and facilitating a smoother research process.
Global expansion of biotechnology firms
The worldwide expansion of biotechnology firms is a substantial force driving the cryogenic freezers market. As these organizations broaden their reach, moving beyond domestic markets into international arenas, the requirement for robust, reliable, and centralized cryogenic storage solutions becomes ever more crucial. These firms are often involved in groundbreaking research and product development activities that span multiple scientific disciplines, from genomics to personalized medicine and even agricultural biotechnology. The value of the biological samples used in such wide-ranging applications is immense, both in terms of financial worth and scientific utility. As the company scales, the complexity of managing these biological assets also increases exponentially. Standardizing storage across multiple locations, while ensuring each meets the necessary quality and safety regulations of their respective jurisdictions, becomes a logistical challenge of significant proportions.
IMARC Group provides an analysis of the key trends in each segment of the global cryogenic freezers market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, application and end use industry.
Tunnel Freezer
IQF Freezer
Immersion Freezer
Spiral Freezer
Others
Tunnel freezer represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product type. This includes tunnel freezer, IQF freezer, immersion freezer, spiral freezer and others. According to the report, tunnel freezer represented the largest segment.
The tunnel freezer segment in the cryogenic freezers market is primarily driven by the increasing demand for fast and efficient freezing solutions in the food and beverage industry. These freezers offer large-scale freezing capacity, which makes them ideal for industrial applications. The rise in the adoption of automation in food processing facilities is contributing to the segment's growth. Additionally, stringent food safety regulations are pushing manufacturers to invest in reliable and quick freezing solutions. Environmental benefits, such as lower energy consumption compared to traditional methods, further boost the segment's attractiveness.
On the other hand, IQF, immersion, and spiral freezers are gaining traction due to their specialized applications in sectors like seafood, fruits, and vegetables. These freezers offer the advantage of freezing individual items quickly, thus maintaining quality. Innovative technological advancements in these freezers are also contributing to market growth.
Corporate Laboratories
Hospitals and Blood Centers
Universities and Research Institutions
Others
Hospitals and blood centers represent the largest market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes corporate laboratories, hospitals and blood centers, universities and research institutions, and others. According to the report, hospitals and blood centers represented the largest segment.
The hospitals and blood centers segment in the cryogenic freezers market is largely propelled by the increasing need for the safe storage of blood, organs, and other biological samples. These freezers are essential for preserving the viability of these biological materials for extended periods. Rising awareness about blood donation and the expansion of healthcare infrastructure globally are other significant factors driving this segment. Strict regulatory guidelines for medical storage conditions also influence the adoption rate of cryogenic freezers in hospitals. Aging populations and the growing prevalence of chronic diseases necessitate more advanced freezing solutions, augmenting market demand.
On the other hand, corporate laboratories, universities, and research institutions employ cryogenic freezers for purposes like tissue storage and long-term biological research. Technological advancements in research methods and the rise in R&D funding contribute to the growth of these segments.
Food and Beverages
Medical and Healthcare
Pharmaceuticals
Chemicals
Others
Medical and healthcare accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end use industry. This includes food and beverages, medical and healthcare, pharmaceuticals, chemicals, and others. According to the report, medical and healthcare represented the largest segment.
The medical and healthcare segment is a prominent driver in the cryogenic freezers market, buoyed by factors like rising pharmaceutical research, the growing requirement for long-term storage of medical supplies, and increasing healthcare expenditure. Enhanced focus on personalized medicine also requires advanced freezing solutions for storing specialized therapies and diagnostics. In addition, the growth in organ transplant procedures globally necessitates reliable freezing technologies for organ preservation. The COVID-19 pandemic has especially emphasized the importance of secure storage solutions for vaccines and other critical medical supplies. The ongoing development and distribution of vaccines also play a pivotal role in boosting this segment.
On the other hand, the food and beverages, pharmaceuticals, and chemicals sectors utilize cryogenic freezers for specific, often specialized, applications. These include the preservation of flavor profiles in food items, storing sensitive pharmaceutical compounds, and maintaining the stability of chemical substances.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest cryogenic freezers market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.
The North America region holds a significant share in the global cryogenic freezers market, driven by factors such as advanced healthcare infrastructure, robust food processing industries, and high R&D spending in both academic and corporate sectors. The presence of major market players in the region also contributes to its dominance.
In addition to this, the increasing awareness regarding blood and organ donations fuels the market, especially in healthcare applications. Regulatory compliance is another key driver, with institutions following strict guidelines for storage solutions. In addition to healthcare, the North American food industry's adoption of high-throughput, automated freezing solutions contributes to market growth.
With the United States and Canada leading in both healthcare and food processing sectors, it significantly influences market trends. Also, the COVID-19 pandemic and the rising prevalence of numerous related diseases has resulted in a significant demand for cryogenic freezers for vaccine storage. Furthermore, the rise in personalized medicine and the adoption of innovative technologies in freezing solutions continue to offer growth opportunities in this region.
The leading companies are making strides in technology to offer better temperature control and energy-efficient solutions. They are collaborating with healthcare and research institutions to understand their specific needs, thereby customizing their product offerings. Emphasis is laid on providing smart features like remote monitoring and data logging to offer added convenience to users. These key players are also exploring emerging markets and establishing distribution channels to widen their global footprint. Investments are made in automation to increase production efficiency and reduce operational costs. Attention is paid to adhering to international quality and safety standards, giving them a competitive edge. Partnerships are often established with local vendors for quicker service and maintenance. These companies are also actively involved in mergers and acquisitions to diversify their product portfolios and expertise.
Thermo Fisher Scientific Inc.
Panasonic Corporation
Chart Industries, Inc.
Haier Group
DAIHAN Scientific
Froilabo
Arctiko
Taylor-Wharton
VRV Group
Aucma Co., Ltd.
Zhongke Meiling Cryogenics Company Limited
In August 2023, Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.
In July 2023, Panasonic Corporation introduced Kinari, a sustainable alternative to traditional plastics. Developed by a team of eco-conscious engineers, Kinari is a high-density material made from cellulose fibers sourced from waste plant materials, bonded with a minimal amount of oil-based resin. The innovation aims to advance sustainability and contribute to a circular society.
In July 2023, Chart Industries, Inc. and New Zealand's Fabrum have partnered to produce and sell Micro-Scale Liquefiers aimed at meeting the growing demand for hydrogen and other gas liquefaction systems. These liquefiers support small-scale liquid hydrogen production and have applications in sustainable transport, industrial use, and energy self-sufficiency.